Sumitomo Chemical (SOMMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 383,414 | -3,193,265 | 1,709 | 2,051,932 | 1,244,720 |
| Depreciation Amortization | 868,540 | 1,086,902 | 1,242,882 | 1,280,064 | 1,228,588 |
| Accounts receivable | -144,962 | 240,106 | 995,293 | -159,041 | -202,565 |
| Accounts payable and accrued liabilities | -40,346 | -222,532 | -470,847 | -320,190 | 436,004 |
| Other Working Capital | 33,429 | 133,964 | -267,184 | -1,150,226 | 930,150 |
| Other Operating Activity | 437,903 | 1,600,738 | -675,857 | -299,524 | -254,511 |
| Operating Cash Flow | $1,537,978 | $-354,087 | $825,995 | $1,403,015 | $3,382,386 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -750,083 | -1,041,307 | -927,590 | -857,341 | -871,114 |
| Net Acquisitions | -77,946 | 142,837 | 95,593 | N/A | -30,304 |
| Purchase Of Investment | 261,829 | -34,307 | N/A | -61,516 | -23,882 |
| Sale Of Investment | 1,207,008 | 675,945 | 366,448 | 135,142 | 189,098 |
| Other Investing Activity | -78,296 | -517,624 | 321,907 | -159,344 | -866,083 |
| Investing Cash Flow | $562,511 | $-774,456 | $-143,641 | $-943,059 | $-1,602,285 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,736,889 | 382,295 | 1,006,097 | 55,903 | -18,065 |
| Debt Issued | 1,670,717 | 737,948 | 489,443 | 661,508 | 3,262,009 |
| Debt Repayment | -1,664,870 | -476,673 | -807,562 | -910,132 | -935,028 |
| Common Stock Repurchased | 44,220 | N/A | N/A | N/A | N/A |
| Dividend Paid | -142,322 | -176,668 | -417,848 | -345,314 | -328,742 |
| Other Financing Activity | -155,991 | -127,105 | -1,591,045 | -127,003 | -2,341,243 |
| Financing Cash Flow | $-1,985,135 | $339,797 | $-1,320,915 | $-665,038 | $-361,069 |
| Exchange Rate Effect | -45,032 | 198,278 | 206,031 | 241,940 | 209,276 |
| Beginning Cash Position | 1,435,163 | 2,110,323 | 2,704,175 | 2,948,917 | 1,631,723 |
| End Cash Position | 1,384,931 | 1,500,398 | 2,263,246 | 2,985,775 | 3,260,031 |
| Net Cash Flow | $-50,233 | $-609,926 | $-440,929 | $36,858 | $1,628,308 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,537,978 | -354,087 | 825,995 | 1,403,015 | 3,382,386 |
| Capital Expenditure | -861,069 | -1,054,824 | -1,062,499 | -878,070 | -1,091,248 |
| Free Cash Flow | 676,909 | -1,408,911 | -236,504 | 524,945 | 2,291,138 |